Research and Innovation 2023 – Accelerating future drug discovery
Wednesday, 29 March 2023 to Thursday, 30 March 2023

Posters

Lane
Dr Jordan Lane
AbsoluteAi
1ATLAS- a Machine Learning Platform for Early Drug Discovery Toxicity Prediction
Profile Poster  
Mohammed
Dr Manal Mohammed
University of Westminster
2Investigating the complex-dynamics of phage-host interaction: Towards effective phage therapy.
Profile Poster  
Zacher
Dr Thorsten Zacher
Pepperprint GmbH
Germany
3Identification of overlapping B-cell and T-cell epitopes
Profile Poster  
Reynisson
Dr Johannes Reynisson
Keele University
4The cytotoxic potential of cationic triangulenes against tumour cells
Profile Poster  
Wigmore
Mrs Cassandra Wigmore
Nebion, an Immunai company
Switzerland
5Unchaining the full potential of public single-cell RNA-Seq data for drug discovery
Profile Poster  
Almahli
Dr Hadia Almahli
University of Cambridge
6The Development of Novel Diagnostics Tools for The Neurodegenerative Diseases
Profile Poster  
Brady
Dr Laura Brady
RCSI
Ireland
7Blockchain and Artificial Intelligence-Enabled Stratified Trial System (BESTS) - A patient driven platform that leverages clinical and genomic data to accelerate clinical trial recruitment for precision therapies
Profile Poster  
Wilson
Dr Cornelia Wilson
Canterbury Christ Church University
8Identification of small molecule stabilizers of the IkB NF-kB p50:p65/RelA complex for lung cancer.
Profile Poster  
Ahmed
Miss Samiyah Ahmed
Astrazeneca
9Recombinant Protein Production for Drug Discovery at AstraZeneca
Profile Poster  
Shahane
Dr Ganesh Shahane
Iktos
France
10Structure-based generative AI for de novo drug design.
Profile Poster  
Singh
Dr Raminderpal Singh
Incubate.bio
11A novel in silico simulation platform to untangle biological pathway mechanisms in Type 1 Diabetes progression
Profile Poster  
Seddighi
Ms Sahba Seddighi
NIH
12Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS/FTD
Profile Poster  
Azzollini
Mrs Lucia Azzollini
Axxam Spa
Italy
13SLC transporters and drug discovery: unlocking the "gatekeepers" as therapeutic targets for rare diseases
  Profile Poster  
Myrbäck
Mr Simon Myrbäck
Cellbox Solutions GmbH
Germany
14Integrated Live Cell Shipment Solution Avoids Cryopreservation for Cell-Based Products
  Profile Poster  
Cresser-Brown
Dr Joel Cresser-Brown
Tocris / Bio-Techne
15Validating Targets for TPD using dTAG – a comprehensive workflow solution
  Profile Poster  
Suchy
Dr Anna Suchy
Selvita
Poland
16Proteins & Structures: High-quality recombinant proteins and structural biology services.
Profile Poster  
Aubert
Dr Sidonie Aubert
Pharmaron
17Investigating CDK4/6 Palbociclib resistance mechanisms in MCF7 breast cancer cell line
Profile Poster  
M Caballero
Dr Isabel M Caballero
Pelago Bioscience AB
Sweden
18Label-free compound profiling in live cells with CETSA®. Case studies with cyclin-dependent kinase 4/6 inhibitors
Profile Poster  
Buzzard
Miss Emma Buzzard
University of Exeter
19Cryo-ET for investigating the role of respiratory chain organisation in health and disease
Profile Poster  
Hammoud
Miss Farah Hammoud
Canterbury Christ Church University
20A Novel Molecular Degrader for the Regulation of the NF-κB Pathway for Non-small Cell Lung Cancer Treatment.
Profile Poster  
Okwera
Miss Lonalisa Okwera
Canterbury Christ church university
21Novel treatment modality for NSCLC in SK-MES-1 cell line targeting the NF-kB pathway.
Profile Poster  
Niemi
Miss Essi M. Niemi
UPM Biomedicals
Finland
22Nanofibrillar Cellulose Hydrogels for Animal-free 3D Cell-Based Assays for High-Throughput Screening Analyses
  Profile Poster  
De Conto
Dr Veronique De Conto
HCS Pharma
France
233D cell culture taking into account the extracellular matrix for bridging the gap between in vitro & in vivo: focus on cancer models
  Profile Poster  
Schnerwitzki
Dr Danny Schnerwitzki
NUVISAN ICB
Germany
24Integrated Drug Discovery and Early Development Services in Age-related diseases
Profile Poster  
Shah
Mr Muji Shah
Promega UK Ltd
26The Spectrum Compact CE System allows laboratories of all sizes the freedom to carry out fragment analysis applications such as single nucleotide polymorphism, PCR sizing and microsatellite analysis, and Sanger sequencing applications.
Profile Poster